Is it a doctor's job to get the best outcomes for their patients or to tell the truth? What happens when these two things are ...
Thea, the AI-powered personalized learning platform headquartered in Arlington, Virginia, today announced that it has ...
A DNA‑based test of the tumour can help two‑thirds of certain breast cancer patients safely avoid chemotherapy without ...
Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes ...
The Prosigna genomic test may help identify breast cancer patients who are likely to gain little benefit from chemotherapy ...
Figuring out how advanced a patient’s Alzheimer’s disease has become could be made much easier with this method.
In cardiology, sex and gender-sensitive diagnosis and treatment planning are crucial, but biological differences remain the ...
Each of my stories includes an original artwork. Clicking on them will take you to their websites. I am grateful for all the ...
Advanced brain imaging using a next-generation tau tracer revealed more Alzheimer’s-related pathology than current methods, ...
Hepta, a liquid biopsy company developing blood tests for chronic disease, today announced clinical data showing its blood ...
RASolute 302 showed daraxonrasib reduced mortality risk by 60% versus chemotherapy in previously treated metastatic PDAC, with median OS 13.2 versus 6.7 months. OPTIMA found Prosigna-defined low-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results